Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
Division of Gynaecology and Human Reproduction Physiopathology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Front Endocrinol (Lausanne). 2024 Mar 7;15:1332673. doi: 10.3389/fendo.2024.1332673. eCollection 2024.
The efficiency of ovarian tissue transplantation (OTT) was established in terms of ovarian function recovery (95% of cases), number of live births (over 200 worldwide to date) and induction of puberty. Unfortunately, the lack of international registries and the fact that many centers have not yet reported their outcomes, lead to poor knowledge of the exact fertility data. The aim of the study is to describe our experience with OTT to restore ovarian function and fertility.
This study was designed as a single-center, observational, retrospective, cohort study that includes women who underwent OTT between December 2012 and June 2023 at our center. After approval by the oncologist/hematologist, a small fragment of ovarian tissue was thawed and analyzed to detect the presence of micrometastases before OTT. Thawed ovarian tissue was grafted laparoscopically at multiple sites, including the remaining ovary and pelvic side wall (orthotopic transplantation) and/or abdominal wall (heterotopic transplantation). After OTT, ovarian function was monitored by hormonal assay, ultrasound and color Doppler at approximately 4-week intervals.
Between December 2012 and June 2023, 30 women performed OTT. Prior to OTT, immunohistochemical and molecular analyses revealed no micrometastases in all thawed ovarian tissue samples. In our series of 30 women, 20 of women were on premature ovarian insufficiency (POI), and the remaining ten cases still had oligomenorrhea and difficulty getting pregnant. Among the women with POI before OTT and at least 6 months follow-up, recovery of endocrine function was observed in all but one woman who underwent orthotopic transplantation (13 of 14 cases), in one out of two women who underwent both orthotopic and heterotopic transplantation (1 of 2 cases) and in all women who underwent heterotopic transplantation (4 of 4 cases). Women who underwent OTT to enhance fertility had no alterations in menstrual cycle and hormonal levels. In total, ten pregnancies were obtained in 25 women, resulting in four live births, two ongoing pregnancies and four spontaneous abortions.
Our data can help patients and physicians in their discussions and decisions about the need and possibilities of preserving fertility.
卵巢组织移植(OTT)的效率已在卵巢功能恢复(95%的病例)、活产数量(全球已有 200 多例)和青春期诱导方面得到证实。遗憾的是,由于缺乏国际登记处,而且许多中心尚未报告其结果,导致对确切的生育数据知之甚少。本研究旨在描述我们使用 OTT 恢复卵巢功能和生育能力的经验。
本研究设计为单中心、观察性、回顾性队列研究,纳入 2012 年 12 月至 2023 年 6 月期间在我院接受 OTT 的女性。在肿瘤学家/血液学家批准后,对小块卵巢组织进行解冻并分析,以检测 OTT 前是否存在微转移。解冻后的卵巢组织通过腹腔镜移植到多个部位,包括剩余卵巢和骨盆侧壁(原位移植)和/或腹壁(异位移植)。OTT 后,大约每 4 周通过激素测定、超声和彩色多普勒监测卵巢功能。
2012 年 12 月至 2023 年 6 月期间,共有 30 名女性进行了 OTT。OTT 前,所有解冻的卵巢组织样本的免疫组化和分子分析均未发现微转移。在我们的 30 名女性系列中,20 名女性患有卵巢早衰(POI),其余 10 名女性仍有月经稀少和怀孕困难。在 OTT 前和至少 6 个月随访时患有 POI 的女性中,除了接受原位移植的 14 例中有 1 例(13 例中的 1 例)、接受原位和异位移植的 2 例中有 1 例(2 例中的 1 例)和接受异位移植的所有女性(4 例中的 4 例)外,内分泌功能均得到恢复。接受 OTT 以增强生育能力的女性月经周期和激素水平没有改变。在总共 25 名接受 OTT 的女性中,获得了 10 次妊娠,导致 4 例活产、2 例持续妊娠和 4 例自然流产。
我们的数据可以帮助患者和医生在讨论和决定是否需要以及是否有可能保留生育能力方面做出决策。